HEMEX Benelux
Vital Decosterstraat 16
3000 Leuven
BE
HEMEX Benelux
Foundation date
01/09/2023
Sector
#Biotechnology / R&D ServicesSubsector
Therapeutic areas
- #Cardiovascular
- #Conditions originating in the perinatal period
- #Diseases of the blood and blood-forming organs - immune disorders
- #Diseases of the nervous system
- #Infectious and parasitic diseases
- #Musculoskeletal system and connective tissue
- #Neoplasms / cancer / oncology
- #Pregnancy - childbirth and the puerperium
- #Respiratory system
- #Skin and subcutaneous tissue
HEMEX, a CRO, provides clinical development services for healthcare SMEs, covering phases from late pre-clinical to phases I-IV, CE-mark applications, and post-market clinical investigations. Our extensive track record encompasses diverse therapeutic areas, including pharmaceuticals, biotechnology, medical devices, IVDs, and digital health. Collaborating with universities, hospitals, professionals, patient groups, and corporations, we have excelled in clinical, regulatory, and quality projects.
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
9 hours ago
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
1 day ago
Read more
-
ExeVir Announces Michael Garrett as New Chief Executive Officer
Tuesday November 19th 2024
Read more
Jobs
More jobs-
-
-
20/11/24
Antwerp
Postdoc position in the Laboratory for Gut-Immune-Brain Axis Research
Permanent
VIB
More info?
Ellen Telleir
Communication Coordinator